• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023

    8/23/23 4:15:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care
    Get the next $ZJYL alert in real time by email

    CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period").

    Financial and Operational Highlights for Six Months Ended March 31, 2023

    • Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.
    • Revenues from wheelchair products were $8.38 million, an increase of 5.4% from $7.95 million for the six months ended March 31, 2022.
    • Revenues from wheelchair components and other products were $1.87 million, an increase of 23.3% from $1.52 million for the six months ended March 31, 2022.
    • Net Income was $1.77 million, an increase of 44.1% from $1.23 million for the six months ended March 31, 2022.
    • Gross profit was $3.53 million, an increase of 12.7% during the period.

    Benefiting from the relaxation of the Zero-COVID policy in the end of 2022 in China, the Company's business operations have gradually recovered and returned to its pre-pandemic level. Additionally, due to the rapid development of China's sharing economy in recent years, shared wheelchairs and other healthcare products have been widely promoted and utilized in Chinese hospitals. To meet the diversified needs of customers, the Company developed and generated revenues from the sales of shared wheelchair-related infrastructure and other shared medical products, which contributed to the growth of the Company's revenue in the six months ended March 31, 2023.

    Mr. Erqi Wang, Chairman and Chief Executive Officer of the Company, commented: "We will consistently adhere to the principles of "care in every product" and the integration of "comfort and design, backed by medical research". We expect that technological innovation will remain the driving force behind the Company's growth and plan to continually cooperate with our R&D partners in the field of rehabilitation, to expand our market share through product development and achieve stable revenue growth."

    About Jin Medical International Ltd.

    The Company, through its Chinese operating entities founded in 2006 and headquartered at Changzhou City, Jiangsu Province of China, designs and manufactures wheelchairs and living aids products for people with disabilities, the elderly, and people recovering from injuries. The Company's Chinese operating entities operate 2 manufacturing plants with approximately 228,257 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. The Company's Chinese operating entities have established relationships with over 40 distributors in China, and over 20 in the other regions of the world where it currently sells the products. The majority of the Company's wheelchair products, with more than 30 models, are sold to dealers in Japan and China, including Nissin Medical Industries Co., Ltd, one of the largest medical device distributors in Japan. The Company's Chinese operating entities own a number of patents with the Patent Administration Department of the People's Republic of China and aims to deliver innovative wheelchair designs that are both lightweight and ergonomic.

    For more information, please visit: http://www.zhjmedical.com.

    Cision View original content:https://www.prnewswire.com/news-releases/jin-medical-international-limited-nasdaq-zjyl-announces-financial-results-for-six-months-ended-march-31-2023-301908416.html

    SOURCE Jin Medical International Ltd

    Get the next $ZJYL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZJYL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZJYL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

    Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. ("Zhongjin Anhui"), has officially launched production at Plant No. 3 of Zhongjin Anhui's intelligent manufacturing facility in Chuzhou, Anhui, China. With 19 years of expertise in rehabilitation technology, the Company is committed to accelerate the integration of the global rehabilitation device supply chain through its robust production and precision manufacturing cap

    7/15/25 9:00:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Jin Medical International Ltd. – Nasdaq Minimum Bid Price Non-Compliance

    Changzhou City, China, May 06, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ:ZJYL) (the "Company") today announced that on May 2, 2025, it received a deficiency letter (the "Notice") from the Nasdaq Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq"). The Notice informed the Company that, based upon the closing bid price of the Company's ordinary shares ("Ordinary Shares") over the 30 consecutive business day period between March 20, 2025 and May 1, 2025, the Company is not in compliance with the requirement to maintain a minimum bid price of $1.00 per share of its Ordinary Shares for continued listing on The Nasdaq Capital Market, as

    5/6/25 4:10:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Construction of JinMed's New Facility Begins in Chuzhou, China

    Chuzhou City, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ:ZJYL), an industrial leader in Assistive Technologies ("AT"), and a manufacturer and developer of wheelchairs and living aids products, today announced the initiation of construction of JinMed's new manufacturing facility at Chuzhou City, Anhui Province, China. JinMed (Anhui) Co., Ltd., a newly established subsidiary of JinMed, will be designated to operate the Chuzhou JinMed plant (the "New Facility") which is established as an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. With higher-level production l

    10/10/24 8:00:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    Financials

    Live finance-specific insights

    View All

    Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023

    CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period"). Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.Revenues from wheelchair products were $8.38 million, an increase of 5.4% from $7.95 million for the six months ended March 31, 2022.Revenues from whee

    8/23/23 4:15:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    SEC Filings

    View All

    SEC Form EFFECT filed by JIN MEDICAL INTERNATIONAL LTD.

    EFFECT - Jin Medical International Ltd. (0001837821) (Filer)

    9/10/25 12:15:12 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Amendment: SEC Form F-3/A filed by JIN MEDICAL INTERNATIONAL LTD.

    F-3/A - Jin Medical International Ltd. (0001837821) (Filer)

    9/3/25 3:31:26 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.

    6-K - Jin Medical International Ltd. (0001837821) (Filer)

    8/20/25 5:15:40 PM ET
    $ZJYL
    Industrial Specialties
    Health Care